Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience.
about
Preventing stem cell transplantation-associated viral infections using T-cell therapyAdvances in understanding and treating dystrophic epidermolysis bullosaAdvances in unrelated and alternative donor hematopoietic cell transplantation for nonmalignant disordersStem Cells: Potential Therapy for Neonatal Injury?National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent NeoplasmsLate Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Inherited Bone Marrow Failure Syndromes (IBMFS): Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on LaCurrent Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium InternatiAllogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.Alternative donor hematopoietic cell transplantation for Fanconi anemiaSecond Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure.Preemptive Bone Marrow Transplantation for FANCD1/BRCA2Fancb deficiency impairs hematopoietic stem cell function.Twenty years of the Italian Fanconi Anemia Registry: where we stand and what remains to be learnedFrom marrow to matrix: novel gene and cell therapies for epidermolysis bullosa.Secondary Malignant Neoplasms Following Haematopoietic Stem Cell Transplantation in ChildhoodLate effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors.Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party.Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Fanconi AnemiaUse of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases.Fanconi anaemia: genetics, molecular biology, and cancer – implications for clinical management in children and adults.Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders.Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations.How I manage patients with Fanconi anaemia.Preemptive Bone Marrow Transplantation and Event-Free Survival in Fanconi Anemia.Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.Successful Outcome With Fludarabine-Based Conditioning Regimen for Hematopoietic Stem Cell Transplantation From Related Donor in Fanconi Anemia: A Single Center Experience From Turkey.Successful treatment of secondary graft failure following unrelated cord blood transplant with hematopoietic growth factors in a pediatric patient with Fanconi anemia.Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.Savior siblings and Fanconi anemia: analysis of success rates from the family's perspective.Replaceable Jejunal Feeding Tubes in Severely Ill ChildrenCancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up.Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study.Transplant results in adults with Fanconi anaemia.Inherited bone marrow failure syndromes: considerations pre- and posttransplant.Risk Stratification of Oral Potentially Malignant Disorders in Fanconi Anemia Patients Using Autofluorescence Imaging and Cytology-On-A Chip Assay.Four decades of stem cell transplantation for Fanconi anaemia in the Netherlands.Variable phenotype of severe immunodeficiencies associated with RMRP gene mutations.Somatic, hematologic phenotype, long-term outcome, and effect of hematopoietic stem cell transplantation. An analysis of 97 Fanconi anemia patients from the Italian national database on behalf of the Marrow Failure Study Group of the AIEOP (Italian A
P2860
Q26801365-0F699AD0-5DDE-4535-A086-CE45B57FDD6AQ27006669-67E07CDB-504B-4435-9630-8E1F53EA644CQ27022561-21176F55-B68F-435D-9941-A6E54F1C8634Q28082268-E52DA57B-8C7E-4F14-BEE9-FDAECCC29726Q29248394-D67B11EC-267F-4535-B414-250DCFF1252FQ30234389-972B2C2F-C208-4F63-AA36-52FB02555219Q30238875-376FCD87-525E-43C8-BE1A-729FA64FCE14Q33430004-FF1098A0-7243-43F1-B61A-C4C2CAA9B2B4Q35724055-3CF043FA-B5FE-4001-BD16-72DB70C3353FQ36055113-D22EEAC8-3A23-44FC-BDA3-546F8BB5B5C4Q36055207-3062EFFF-6D5E-4B9A-AC37-F3DD92246EC3Q36364040-46137D4C-B1A7-4E13-A961-8FA6690E20DAQ36750453-810BEE39-7A95-4416-8CFE-5217917D5173Q36756725-44568C92-8E36-4ABF-BC5D-14DCBD52C184Q37055896-9F4EE1F9-F829-4E80-AA84-A2DF6162B219Q37143051-72164032-84FA-4655-B058-21DE2FD44992Q37216480-52CABB0A-FAA2-4608-9794-1881E8118D37Q37417561-18A99028-C3BD-4C4F-B558-1AE4D1A142ABQ37600436-894726F5-F06F-4180-AC72-0DFFB38A307BQ38259296-AA4767B7-C8C2-4556-8521-AF6D69DEAA0DQ38387292-BEE5C4A2-16F1-4DF0-840A-20A9A6916695Q38520096-2B4A2A63-E9DA-40AB-9261-5D501FA1F56EQ38845467-97B9A5CF-D4A4-441F-A9F4-7024CB304B5BQ39032775-2360595C-C1E2-4115-BD61-3D0CD851AFF4Q39285296-470E2247-9363-43D5-952F-92C677096279Q39654436-271C381F-576D-45E7-9AF5-9289CEB8634AQ40896067-83F288AD-7F33-4F6E-88BF-18BFCC06EFCAQ41022642-C8F2DC96-2779-45EC-9B32-2FF8362E1177Q41080022-CFBB22FC-63C9-4362-963E-4897B504B5B8Q41344437-9AD96D80-48F2-46C1-A804-727B1A010166Q41445829-A90763D1-3F15-4937-B394-43C32202FDA6Q42324053-F80E770B-288E-4B83-A678-C46C8CEA7E2EQ47238705-E918159E-4256-4069-B4BB-1238D03B27D1Q48260216-EF814066-021D-4C0F-A80D-758EA7E8482FQ48378443-516FD092-DF6B-492E-B039-294266CC0731Q49789092-20C601C1-3C82-4FD5-B0E9-D50F46C3D53AQ51418953-568F7A18-C788-4D93-BE5C-4BD477F869D3Q52984834-1613844E-E016-40E3-9784-A48EAFB45A4AQ53622501-542C2040-DE02-41C7-88E2-C881522662CAQ57943230-E49ADA06-FB0D-48D6-AE3F-B0EB4807FEA9
P2860
Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Allogeneic hematopoietic stem ...... ow Transplantation experience.
@en
Allogeneic hematopoietic stem ...... ow Transplantation experience.
@nl
type
label
Allogeneic hematopoietic stem ...... ow Transplantation experience.
@en
Allogeneic hematopoietic stem ...... ow Transplantation experience.
@nl
prefLabel
Allogeneic hematopoietic stem ...... ow Transplantation experience.
@en
Allogeneic hematopoietic stem ...... ow Transplantation experience.
@nl
P2093
P50
P1433
P1476
Allogeneic hematopoietic stem ...... ow Transplantation experience.
@en
P2093
Andrea Bacigalupo
Carlo Dufour
Christina Peters
Cristina Barrenetxea
Elisabeth T Korthof
FA Committee of the Severe Aplastic Anemia Working Party
Jean Soulier
Jean-Hugues Dalle
Johanna Svahn
Judith C W Marsh
P304
P356
10.1182/BLOOD-2013-01-479733
P407
P577
2013-10-21T00:00:00Z